Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | PRNP | P04156 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19063374 | 0.79 | RCE1 (0.38) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL19064470 | 0.78 | KDM4E (0.44) | ALDH1A1CYP1A2CYP2C9HPGDSMN1; SMN2 | |
| SCHEMBL19080431 | 0.77 | CYP1A2 (0.42) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL19080434 | 0.76 | CYP1A2 (0.41) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL19064465 | 0.72 | HPRT1 (0.38) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL5084276 | 0.72 | ALDH1A1 (0.40) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL19063384 | 0.70 | MAPT (0.63) | ALDH1A1HPRT1MEN1MAPTHPGD | |
| SCHEMBL19080430 | 0.70 | POLB (0.47) | CYP2C19ALDH1A1CYP1A2CYP2C9HPRT1 | |
| SCHEMBL19064466 | 0.70 | HPRT1 (0.39) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL13755371 | 0.70 | ALDH1A1 (0.37) | CYP2D6CYP2C19ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194571-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNA1 | CYP2D6 1892/4885CYP2C19 249/4885ALDH1A1 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.